Multiple lines of evidence suggests that estrogen(E) directly modulates angiogenesis. Under physiologic conditions, angiogenesis is routinely observed in the uterus in association with fluctuations in the levels of circulating estradiol(E2) and other sex steroids. In pathologic circumstances, such as breast cancer, a clear association between E, estrogen receptor (ER) expression, angiogenic activity and tumor invasiveness has been drawn. Despite These consistent observations, the mechanisms by which E regulates angiogenesis under physiologic and pathologic circumstances have not been defined. Prior studies indicate that hematopoietic stem cells (HSCs) and endothelial progenitor cells (EPCs) are derived from a common precursor, the hemangioblast. Based on these studies our laboratory investigated the possibilities that stem cells derived from peripheral blood could differentiation into endothelial cells (EC) and thereby participate in angiogenesis. Additional preliminary marrow (BM) derived EPC and the incorporation of these precursors into foci of vasculogenesis. Accordingly, the proposed studies are designed to clarify and extend these preliminary findings. These studies are organized to examine hypotheses the following specific aims:
SPECIFIC AIM 1 : Define Modulation of EPC kinetics y Estrogen;
SPECIFIC AIM 2 : Define the Role of Estrogen Receptor in Estrogen-induced, EPC-mediated Neovascularization;
SPECIFIC AIM 3 : Investigate Certain Mechanisms which Mediate Estrogen-Induced, EPC-Derived Neovascularization. Our preliminary data provide evidence that E2 induced neovascularization is the result, at least in part, of vasculogenesis resulting from recruitment and incorporation of BM derived EPC. These data are in contrast to the conventional paradigm of angiogenesis (i.e. sprouts derived from pre-existing, fully differentiated EC) which has been assumed to account for E2 induced blood vessel formation. The study of neovascularization in the model for E2 induction will provide the opportunity to examine these mechanisms in a physiologically relevant context and thereby discern certain fundamental mechanisms responsible for post-natal neovascularization.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL063695-01A1
Application #
6285931
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Program Officer
Goldman, Stephen
Project Start
2000-12-18
Project End
2004-11-30
Budget Start
2000-12-18
Budget End
2001-11-30
Support Year
1
Fiscal Year
2001
Total Cost
$416,250
Indirect Cost
Name
St. Elizabeth's Medical Center of Boston
Department
Type
DUNS #
073797292
City
Boston
State
MA
Country
United States
Zip Code
01235
Ii, Masaaki; Hoshiga, Masaaki; Negoro, Nobuyuki et al. (2009) Adrenal androgen dehydroepiandrosterone sulfate inhibits vascular remodeling following arterial injury. Atherosclerosis 206:77-85
Losordo, Douglas W; Kishore, Raj (2009) A big promise from the very small identification of circulating embryonic stem-like pluripotent cells in patients with acute myocardial infarction. J Am Coll Cardiol 53:10-2
Jujo, Kentaro; Ii, Masaaki; Losordo, Douglas W (2008) Endothelial progenitor cells in neovascularization of infarcted myocardium. J Mol Cell Cardiol 45:530-44
Ii, Masaaki; Losordo, Douglas W (2007) Statins and the endothelium. Vascul Pharmacol 46:1-9
Sinha, Sudha; Poh, Kian-Keong; Sodano, Donato et al. (2006) Safety and efficacy of peripheral blood progenitor cell mobilization and collection in patients with advanced coronary heart disease. J Clin Apher 21:116-20
Yoon, Young-sup; Wecker, Andrea; Heyd, Lindsay et al. (2005) Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 115:326-38
Ii, Masaaki; Nishimura, Hiromi; Kusano, Kengo F et al. (2005) Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy. Circulation 112:93-102
Ii, Masaaki; Nishimura, Hiromi; Iwakura, Atsushi et al. (2005) Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via ""imported"" nitric oxide synthase activity. Circulation 111:1114-20
Kirchmair, Rudolf; Walter, Dirk H; Ii, Masaaki et al. (2005) Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth. Circulation 111:2662-70
Yoon, Young-sup; Uchida, Shigeki; Masuo, Osamu et al. (2005) Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of Circulation 111:2073-85

Showing the most recent 10 out of 25 publications